Rituximab plus IV immune globulin for transplant desensitisation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1648, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab plus IV immune globulin is an effective treatment for patients with refractory pemphigus vulgaris

By  

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Immune globulin: Anaphylaxis, with subsequent desensitisation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Immune globulin: Anaphylactic reaction in an elderly patient, managed with desensitisation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Rituximab: Immune globulin deficiency and corynebacterium pneumonia in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite

Immune globulin: Thrombosis in renal transplant recipients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite